Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

BACKGROUND: The effects of pan-peroxisome proliferator-activated receptor (PPAR) ligand bezafibrate on N-terminal pro-B type natriuretic peptide (ProBNP) level in patients with coronary artery disease (CAD) is unknown. The current study aimed to investigate the long-term effects of bezafibrate on Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Node, Koichi, Inoue, Teruo, Boyko, Valentin, Goldberg, Ilan, Fisman, Enrique Z, Adler, Yehuda, Schwammenthal, Ehud, Matas, Zipora, Behar, Solomon, Tenenbaum, Alexander
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645368/
https://www.ncbi.nlm.nih.gov/pubmed/19173749
http://dx.doi.org/10.1186/1475-2840-8-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645368/
https://www.ncbi.nlm.nih.gov/pubmed/19173749
http://dx.doi.org/10.1186/1475-2840-8-5

Ejemplares similares